Literature DB >> 9158032

Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants: a report of the Collaborative Transplant Study.

J Mytilineos1, A Deufel, G Opelz.   

Abstract

BACKGROUND: Matching for the HLA class I loci A and B and for the HLA class II locus DRB is known to influence the survival rate of kidney transplants. It is unknown whether matching for the HLA class II locus DPB also exerts an influence on graft outcome.
METHODS: The influence of matching for the HLA-DPB locus was analyzed based on DNA typing results obtained in more than 3600 first and 1300 repeat cadaver kidney transplants.
RESULTS: HLA-DPB mismatches had no deleterious influence on the outcome of first cadaver transplants. However, the influence was statistically significant for retransplants. One-year graft survival rates were 83+/-2% with no mismatch (n=345), as compared with 76+/-2% with one mismatch (n=702, P=0.02), and 73+/-3% with two mismatches (n=258, P=0.003). The deleterious influence of HLA-DPB mismatches was particularly strong in retransplant recipients with >50% reactivity of preformed lymphocytotoxic antibodies, for which the 1-year graft survival rate was 70+/-4% with no mismatch, as compared with 69+/-3% with one mismatch (P=0.05) and 61+/-5% with two mismatches (P=0.003).
CONCLUSIONS: These results indicate that HLA-DPB is a clinically relevant histocompatibility locus in cadaver kidney retransplantation. It is proposed that prospective typing and matching for HLA-DPB should be implemented for cadaver kidney retransplants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158032     DOI: 10.1097/00007890-199705150-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Authors:  Rene J Duquesnoy; Medhat Askar
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

Review 2.  Non-HLA donor-recipient mismatches in kidney transplantation-A stone left unturned.

Authors:  Samira Farouk; Zhongyang Zhang; Madhav C Menon
Journal:  Am J Transplant       Date:  2019-10-19       Impact factor: 8.086

3.  Resolving MiSeq-Generated Ambiguities in HLA-DPB1 Typing by Using the Oxford Nanopore Technology.

Authors:  Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Nilesh Chitnis; Taishan Hu; Nikolaos Tairis; David J Margolis; Dimitri S Monos
Journal:  J Mol Diagn       Date:  2019-06-04       Impact factor: 5.568

4.  Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.

Authors:  Beata Mierzejewska; Paul M Schroder; Caitlin E Baum; Annette Blair; Connie Smith; Rene J Duquesnoy; Marilyn Marrari; Amira Gohara; Deepak Malhotra; Dinkar Kaw; Robert Liwski; Michael A Rees; Stanislaw Stepkowski
Journal:  Hum Immunol       Date:  2014-04-19       Impact factor: 2.850

5.  Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

Authors:  Rene J Duquesnoy; Yehia Awadalla; Jon Lomago; Larry Jelinek; Judy Howe; Dwayne Zern; Betty Hunter; Joan Martell; Alin Girnita; Adriana Zeevi
Journal:  Transpl Immunol       Date:  2007-10-30       Impact factor: 1.708

6.  Genetic variants in major histocompatibility complex-linked genes associate with pediatric liver transplant rejection.

Authors:  Rakesh Sindhi; Brandon W Higgs; Daniel E Weeks; Chethan Ashokkumar; Ronald Jaffe; Cecilia Kim; Patrick Wilson; Nydia Chien; Joseph Glessner; Anjan Talukdar; George Mazariegos; M Michael Barmada; Edward Frackleton; Nancy Petro; Andrew Eckert; Hakon Hakonarson; Robert Ferrell
Journal:  Gastroenterology       Date:  2008-06-03       Impact factor: 22.682

7.  Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.

Authors:  E C Jolly; T Key; H Rasheed; H Morgan; A Butler; N Pritchard; C J Taylor; M R Clatworthy
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

8.  Cytotoxic antibodies--valuable prognostic factor for long term kidney allograft survival.

Authors:  Ana Moise; Daniela Nedelcu; Adela Toader; Mihaela Sora; Anca Tica; Denisa Elena Ferastraoaru; Ileana Constantinescu
Journal:  J Med Life       Date:  2010 Oct-Dec

Review 9.  HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act.

Authors:  Andrea A Zachary; Mary S Leffell
Journal:  Front Immunol       Date:  2016-12-07       Impact factor: 7.561

10.  Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.

Authors:  Dermot H Mallon; Christiane Kling; Matthew Robb; Eva Ellinghaus; J Andrew Bradley; Craig J Taylor; Dieter Kabelitz; Vasilis Kosmoliaptsis
Journal:  J Immunol       Date:  2018-11-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.